MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
PHQ (Patient Health Questionnaire) PDF Print E-mail

Developed by:
Robert L. Spitzer, MD, Kurt Kroenke, MD, Janet B.W. Williams, DSW (USA)

Objective:
To diagnose signs of mental health disorders  

Copyright:
PHQ © Pfizer Inc. All rights reserved.

Reference publications:
Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 1999; 282(18):1737-1744.



Conditions of use:


1. User-Agreement

User is required to complete and sign a User Agreement in which specific conditions requested by the authors are detailed.


2. Access fees

carre6 Distribution fees

Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study + 50 € per language version 

- In commercial studies (3) involving "for-profit" organizations and academic studies funded by commercial companies: 500 €* per study + 150 € per language version. 


* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies)



Review Copy:


Please click here to access a Review Copy of the PHQ Screener

Please click here to access a Review Copy of the Brief PHQ Screener

Please click here to access a Review Copy of the PHQ-9 Depression Screener


Contact information:

MAPI Research Trust
Christelle Berne

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82

This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Please note that you may contact Dr. Kroenke directly for specific questions on the PHQ: This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


Coming soon! More information on the PHQ on PROQOLID


[ BACK ]

 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org